Company that detected impurities in ranitidine drugs says FDA testing methodology is insufficient, while FDA counters that the company’s testing method was inaccurate
The results of a recent study raise questions about whether current surface detection methods allow people living inside a former meth house to understand the extent of contamination that's present,